G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery
- PMID: 38594257
- PMCID: PMC11004190
- DOI: 10.1038/s41392-024-01803-6
G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery
Abstract
G protein-coupled receptors (GPCRs), the largest family of human membrane proteins and an important class of drug targets, play a role in maintaining numerous physiological processes. Agonist or antagonist, orthosteric effects or allosteric effects, and biased signaling or balanced signaling, characterize the complexity of GPCR dynamic features. In this study, we first review the structural advancements, activation mechanisms, and functional diversity of GPCRs. We then focus on GPCR drug discovery by revealing the detailed drug-target interactions and the underlying mechanisms of orthosteric drugs approved by the US Food and Drug Administration in the past five years. Particularly, an up-to-date analysis is performed on available GPCR structures complexed with synthetic small-molecule allosteric modulators to elucidate key receptor-ligand interactions and allosteric mechanisms. Finally, we highlight how the widespread GPCR-druggable allosteric sites can guide structure- or mechanism-based drug design and propose prospects of designing bitopic ligands for the future therapeutic potential of targeting this receptor family.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig1_HTML.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig2_HTML.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig3_HTML.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig4_HTML.gif)
![Fig. 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig5_HTML.gif)
![Fig. 6](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig6_HTML.gif)
![Fig. 7](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig7_HTML.gif)
![Fig. 8](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig8_HTML.gif)
![Fig. 9](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig9_HTML.gif)
![Fig. 10](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig10_HTML.gif)
![Fig. 11](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig11_HTML.gif)
![Fig. 12](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig12_HTML.gif)
![Fig. 13](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig13_HTML.gif)
![Fig. 14](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig14_HTML.gif)
![Fig. 15](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig15_HTML.gif)
![Fig. 16](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig16_HTML.gif)
![Fig. 17](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig17_HTML.gif)
![Fig. 18](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig18_HTML.gif)
![Fig. 19](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig19_HTML.gif)
![Fig. 20](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig20_HTML.gif)
![Fig. 21](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig21_HTML.gif)
![Fig. 22](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig22_HTML.gif)
![Fig. 23](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig23_HTML.gif)
![Fig. 24](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig24_HTML.gif)
![Fig. 25](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig25_HTML.gif)
![Fig. 26](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig26_HTML.gif)
![Fig. 27](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig27_HTML.gif)
![Fig. 28](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig28_HTML.gif)
![Fig. 29](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig29_HTML.gif)
![Fig. 30](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig30_HTML.gif)
![Fig. 31](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig31_HTML.gif)
![Fig. 32](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig32_HTML.gif)
![Fig. 33](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig33_HTML.gif)
![Fig. 34](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig34_HTML.gif)
![Fig. 35](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11004190/bin/41392_2024_1803_Fig35_HTML.gif)
Similar articles
-
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.J Med Chem. 2019 Jan 10;62(1):24-45. doi: 10.1021/acs.jmedchem.7b01844. Epub 2018 Feb 26. J Med Chem. 2019. PMID: 29457894
-
Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.Pharmacol Ther. 2022 Sep;237:108242. doi: 10.1016/j.pharmthera.2022.108242. Epub 2022 Jul 18. Pharmacol Ther. 2022. PMID: 35863587 Review.
-
Pharmacologically targeting intracellular allosteric sites of GPCRs for drug discovery.Drug Discov Today. 2023 Dec;28(12):103803. doi: 10.1016/j.drudis.2023.103803. Epub 2023 Oct 17. Drug Discov Today. 2023. PMID: 37852356 Review.
-
Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.Curr Top Med Chem. 2019;19(26):2378-2392. doi: 10.2174/1568026619666191009164609. Curr Top Med Chem. 2019. PMID: 31833462 Review.
-
Current and Future Challenges in GPCR Drug Discovery.Methods Mol Biol. 2018;1705:1-21. doi: 10.1007/978-1-4939-7465-8_1. Methods Mol Biol. 2018. PMID: 29188556 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous